Canada once had a biotechnology strategy that, despite its flaws and poor execution, sent a signal that biotech firms should open up shop in Canada.
Industry advocates say it's time to consider a new biotechnology or bioeconomy strategy in an increasingly complex technological and regulatory environment. Photograph courtesy of Flickr
With Canada’s biotechnology sector showing signs of new growth, industry advocates say it’s time the federal government consider a national biotech strategy, more than a decade after one created in 1998 was nixed by the Conservative government.
People. Policy. Politics. This is an exclusive subscriber-only story.
CanCon Contributions & Quotas In a Digital Age As part of Heritage Canada’s review of Canadian content in a digital age, various parties are proposing changes to how digital services are regulated and taxed.
As internationally mediated talks between the Venezuelan regime and opposition break down, lawmakers and experts are skeptical about the path forward, and are divided on Canada's role in solving the crisis.
There’s an inherent tension at play between journalism’s interest in news value and the public interest, says Elly Alboim, former CBC journalist, who doesn't think debates should be treated as a 'journalistic exercise.'